Skip to main content

Table 2 Demographics and baseline characteristics (treated set)

From: The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study

Randomised volunteers, n 30
   Male gender, n (%) 16 (53.3)
   Number completing study, n (%) 27 (90.0)
Baseline characteristics Median (range)
   Age (years) 32.5 (18−52)
   Height (cm) 170.5 (161−184)
   Weight (kg) 68.0 (52−88)
   BMI (kg/m2) 23.2 (19.1−28.4)
   Heart rate (bpm) 56.0 (42.0−75.0)
   QT interval (ms) 403.5 (363.0−475.0)
   QTcN interval (ms) 399.0 (372.5−440.3)
  1. BMI, body mass index; bpm, beats per minute; QTcN, population heart rate-corrected QT interval.